{"id":"W2892018897","doi":"10.1016/j.phrs.2018.09.007","title":"Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug","year":2018,"lang":"en","type":"article","venue":"Pharmacological Research","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Alberta Children's Hospital; University of Calgary","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Neurological Disorders and Stroke; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Muscular Dystrophy Association; U.S. Department of Defense","keywords":"Pharmacodynamics; Duchenne muscular dystrophy; Medicine; Pharmacology; Pharmacokinetics; Drug; Internal medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001688453,0.0002383317,0.0003585987,0.0001774671,0.0002353828,0.00003011735,0.0005199614,0.000316752,0.0008318421],"category_scores_gemma":[0.0005747902,0.0002061118,0.000150955,0.0003898337,0.0007826544,0.00001481404,0.0004486609,0.0007076365,0.00009570375],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008966785,"about_ca_system_score_gemma":0.0001576811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007351329,"about_ca_topic_score_gemma":0.0002498986,"domain_scores_codex":[0.9964647,0.0009760367,0.0004007268,0.0007935539,0.0003986739,0.0009663454],"domain_scores_gemma":[0.9990103,0.0002063401,0.00007754871,0.0002809687,0.0002110411,0.0002138591],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.04892006,0.003393492,0.003269005,0.00003382022,0.000144996,0.0001181646,0.0005488206,0.00002267529,0.93175,0.00007646152,0.01048549,0.001237009],"study_design_scores_gemma":[0.302556,0.01814692,0.04041773,0.00006823908,0.00008733171,0.000005887124,0.001080764,0.003224344,0.5678282,0.002686628,0.06233629,0.001561748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996142,0.0003576798,0.00001481198,0.00134277,0.0002125471,0.001014082,0.00003738885,0.00001522549,0.0008634573],"genre_scores_gemma":[0.99775,0.0003591754,0.00002849412,0.0005163936,0.0006615632,0.0003298252,0.00004676716,0.0000202849,0.00028746],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3639219,"threshold_uncertainty_score":0.9108088,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05312323704595653,"score_gpt":0.412047690765389,"score_spread":0.3589244537194325,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}